Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$3.72 - $9.0 $361,896 - $875,556
-97,284 Closed
0 $0
Q1 2022

May 11, 2022

BUY
$8.19 - $13.89 $125,847 - $213,433
15,366 Added 18.76%
97,284 $842,000
Q4 2021

Feb 11, 2022

BUY
$12.98 - $29.75 $152,800 - $350,217
11,772 Added 16.78%
81,918 $1.17 Million
Q3 2021

Nov 12, 2021

BUY
$12.13 - $23.82 $209,145 - $410,704
17,242 Added 32.59%
70,146 $1.54 Million
Q2 2021

Aug 11, 2021

BUY
$8.34 - $14.59 $441,219 - $771,869
52,904 New
52,904 $707,000

Others Institutions Holding ORMP

About ORAMED PHARMACEUTICALS INC.


  • Ticker ORMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,100
  • Market Cap $92.4M
  • Description
  • Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...
More about ORMP
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.